NO176043C - Fremgangsmåte til fremstilling av en kolestyramintablett - Google Patents

Fremgangsmåte til fremstilling av en kolestyramintablett

Info

Publication number
NO176043C
NO176043C NO901183A NO901183A NO176043C NO 176043 C NO176043 C NO 176043C NO 901183 A NO901183 A NO 901183A NO 901183 A NO901183 A NO 901183A NO 176043 C NO176043 C NO 176043C
Authority
NO
Norway
Prior art keywords
preparation
cholestyramine
tablet
cholestyramine tablet
Prior art date
Application number
NO901183A
Other languages
English (en)
Norwegian (no)
Other versions
NO901183D0 (no
NO901183L (no
NO176043B (no
Inventor
Robert J Bequette
Bruce A Bonenberger
Claude E Gallian
John R Reckelhoff
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO901183D0 publication Critical patent/NO901183D0/no
Publication of NO901183L publication Critical patent/NO901183L/no
Publication of NO176043B publication Critical patent/NO176043B/no
Publication of NO176043C publication Critical patent/NO176043C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO901183A 1989-03-16 1990-03-14 Fremgangsmåte til fremstilling av en kolestyramintablett NO176043C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (4)

Publication Number Publication Date
NO901183D0 NO901183D0 (no) 1990-03-14
NO901183L NO901183L (no) 1990-09-17
NO176043B NO176043B (no) 1994-10-17
NO176043C true NO176043C (no) 1995-01-25

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901183A NO176043C (no) 1989-03-16 1990-03-14 Fremgangsmåte til fremstilling av en kolestyramintablett

Country Status (34)

Country Link
US (1) US4956182A (de)
EP (1) EP0387885B1 (de)
JP (1) JP2974719B2 (de)
KR (1) KR0140211B1 (de)
CN (1) CN1047935C (de)
AR (1) AR246012A1 (de)
AT (1) ATE128031T1 (de)
AU (1) AU617601B2 (de)
BG (1) BG60501B1 (de)
CA (1) CA2012300A1 (de)
CS (1) CS277488B6 (de)
CY (1) CY1899A (de)
DD (1) DD292837A5 (de)
DE (1) DE69022452T2 (de)
DK (1) DK0387885T3 (de)
EG (1) EG19669A (de)
ES (1) ES2078917T3 (de)
FI (1) FI92464C (de)
GR (1) GR3017460T3 (de)
HK (1) HK51396A (de)
HU (1) HU209958B (de)
IE (1) IE70591B1 (de)
IL (1) IL93720A0 (de)
MY (1) MY109744A (de)
NO (1) NO176043C (de)
NZ (1) NZ232864A (de)
OA (1) OA09198A (de)
PL (1) PL163301B1 (de)
PT (1) PT93452B (de)
RO (1) RO106953B1 (de)
RU (1) RU2069558C1 (de)
YU (1) YU52390A (de)
ZA (1) ZA902001B (de)
ZW (1) ZW1890A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
EP0782449B1 (de) * 1994-09-22 2003-04-09 Akzo Nobel N.V. Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (de) 1999-10-29 2011-03-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
EP1368006B1 (de) * 2001-02-13 2006-05-03 AstraZeneca AB Neue formulierung mit modifizierter freisetzung
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
MXPA04002973A (es) 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosis de liberacion modificada.
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
RU2234915C2 (ru) * 2002-06-04 2004-08-27 Дж. Б. Кемикалс энд Фармасьютикалс Лтд. Твердая фармацевтическая композиция для перорального введения и способ ее получения
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
WO2005115352A1 (de) * 2004-05-24 2005-12-08 Mepha Ag Trockenbeschichtungsverfahren
EP2039349A1 (de) * 2004-10-19 2009-03-25 KRKA, tovarna zdravil, d.d., Novo mesto Feste pharmazeutische Zusammensetzung mit Donepezilhydrochlorid
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
CN103027896B (zh) 2005-09-15 2016-01-20 基酶有限公司 胺聚合物的小袋制剂
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
JP5301273B2 (ja) 2006-08-09 2013-09-25 田辺三菱製薬株式会社 錠剤
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
WO2013158814A1 (en) 2012-04-18 2013-10-24 Mallinckrodt Llc Immediate release, abuse deterrent pharmaceutical compositions
KR20160077138A (ko) 2013-10-25 2016-07-01 주식회사 쿠라레 복층 필름 및 그것으로 이루어지는 접합 유리용 중간막
PL3164117T3 (pl) 2014-07-03 2024-03-11 SpecGx LLC Preparaty zapewniające natychmiastowe uwalnianie i powstrzymujące przed nadużywaniem, zawierające polisacharydy inne niż celuloza
CA3011595C (en) * 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CN108601744B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
EP0387885A2 (de) 1990-09-19
RO106953B1 (ro) 1993-08-30
KR0140211B1 (ko) 1998-06-01
NO901183D0 (no) 1990-03-14
YU52390A (en) 1991-10-31
EP0387885A3 (de) 1992-06-17
ZW1890A1 (en) 1990-10-31
EP0387885B1 (de) 1995-09-20
FI92464C (fi) 1994-11-25
HU901429D0 (en) 1990-06-28
NZ232864A (en) 1992-04-28
GR3017460T3 (en) 1995-12-31
EG19669A (en) 1995-08-30
NO901183L (no) 1990-09-17
IE70591B1 (en) 1996-12-11
DK0387885T3 (da) 1995-11-06
NO176043B (no) 1994-10-17
ATE128031T1 (de) 1995-10-15
FI92464B (fi) 1994-08-15
PT93452A (pt) 1990-11-07
JP2974719B2 (ja) 1999-11-10
CY1899A (en) 1990-03-15
IL93720A0 (en) 1990-12-23
OA09198A (fr) 1992-06-30
MY109744A (en) 1997-05-31
DD292837A5 (de) 1991-08-14
PT93452B (pt) 1996-12-31
AU617601B2 (en) 1991-11-28
FI901241A0 (fi) 1990-03-13
CN1047935C (zh) 2000-01-05
CN1045921A (zh) 1990-10-10
IE900941L (en) 1990-09-16
HU209958B (en) 1994-12-28
BG60501B1 (bg) 1995-06-30
BG91463A (bg) 1993-12-24
AR246012A1 (es) 1994-03-30
PL163301B1 (en) 1994-03-31
DE69022452D1 (de) 1995-10-26
HK51396A (en) 1996-03-29
CS277488B6 (en) 1993-03-17
CA2012300A1 (en) 1990-09-16
KR900013946A (ko) 1990-10-22
HUT54489A (en) 1991-03-28
AU5136790A (en) 1990-09-20
RU2069558C1 (ru) 1996-11-27
JPH03236326A (ja) 1991-10-22
US4956182A (en) 1990-09-11
ES2078917T3 (es) 1996-01-01
DE69022452T2 (de) 1996-03-14
ZA902001B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
FI901241A0 (fi) Menetelmä kolestyyriamiinitabletin valmistamiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
NO904513D0 (no) Fremgangsmaate for fremstilling av et naeringsmiddel.
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
NO171792C (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer
FI890186A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
FI890185A7 (fi) Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
NO173280C (no) Fremgangsm}te for fremstilling av colestipolhydroklorid
GB8916682D0 (en) Pharmaceutical compounds
FI890188A7 (fi) Menetelmä 1-hydroksialkyyli-2-metyyli-5-nitroimidatsolien valmistamiseksi
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
FI902590A7 (fi) Menetelmä 2-oksoindoli-1-karboksamidien valmistamiseksi
NO904643L (no) Fremgangsmaate til fremstilling av en for sproeytestoeping egnet vinylklorid/butylakrylat-podekopolymer.
NO905000D0 (no) Fremgangsmaate for fremstilling av et polymersystem for vanneroderbare belegg.
FI93363C (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi
GB2198732B (en) Process for the manufacture of photopolymerisable materials
FI904950A7 (fi) Menetelmä 3-alkoksi-4-hydroksibentsaldehydien valmistamiseksi
NO963876L (no) Fremgangsmåte for fremstilling av polypeptider
NO942454D0 (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
NO174554C (no) Fremgangsmåte til fremstilling av 1,2:3,5-di-O-iso-propyliden-
NO960829D0 (no) Fremgangsmåte for fresmtilling av 13-alkyl-11 r
NO940861D0 (no) Fremgangsmåte for fremstilling av substituerte 2-aminoteraliner
CA64087S (en) Tablet
CA63453S (en) Tablet

Legal Events

Date Code Title Description
MK1K Patent expired